BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-9 out of 9 found
  Current Search:  paget: 18, disease: 7454, breast: 9329, mammary: 11     

HTML
50%
Atossa Genetics, Inc. Appoints Edward Sauter, M.D., Ph.D., to Its Scientific Advisory Board
Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer, including the FDA approved Mammary Aspirate Specimen Cytology...
RBC Dain Rauscher:  Feb 28 2010 12:45PM
Matching: breast mammary
Find similar documents
HTML
50%
Atossa Genetics, Inc. Appoints Edward Sauter, M.D., Ph.D., to Its Scientific Advisory Board
SEATTLE, WA -- (Marketwire) -- 02/25/10 -- Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer, including the FDA...
PR inside:  Feb 25 2010 6:00PM
Matching: breast mammary
Find similar documents
HTML
50%
Atossa Genetics, Inc. Appoints Edward Sauter, M.D., Ph.D., to Its Scientific Advisory Board
Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer, including the FDA approved Mammary Aspirate Specimen Cytology...
Individual.com:  Feb 25 2010 5:38PM
Matching: breast mammary
Find similar documents
HTML
50%
2/8/10 - Atossa Genetics, Inc. Launches Corporate Web Site Featuring New FDA-Approved Breast Cancer Risk Asses
SEATTLE, WA (MARKET WIRE) 02/08/10 Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer, announced today the launch of its...
Pharmacy Choice:  Feb 9 2010 12:17AM
Matching: breast mammary
Find similar documents
HTML
50%
Atossa Genetics, Inc. Launches Corporate Web Site Featuring New FDA-Approved Breast Cancer Risk Assessment Tes
Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer, announced today the launch of its new Web site at http://www...
RBC Dain Rauscher:  Feb 9 2010 2:02AM
Matching: breast mammary
Find similar documents
HTML
50%
Atossa Genetics, Inc. Launches Corporate Web Site Featuring New FDA-Approved Breast Cancer Risk Assessment Tes
SEATTLE, WA (MARKET WIRE) 02/08/10 Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer, announced today the launch of its...
Pharmacy Choice:  Feb 8 2010 9:34PM
Matching: breast mammary
Find similar documents
HTML
50%
Atossa Genetics, Inc. Launches Corporate Web Site Featuring New FDA-Approved Breast Cancer Risk Assessment Tes
SOURCE: Atossa Genetics, Inc.

SEATTLE, WA--(Marketwire - February 8, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast...

Market Wire:  Feb 8 2010 1:50PM
Matching: breast mammary
Find similar documents
HTML
50%
Atossa Genetics, Inc. Launches Corporate Web Site Featuring New FDA-Approved Breast Cancer Risk Assessment Test
Companies mentioned in this article: Atossa Genetics, Inc.

SEATTLE, WA -- (Marketwire) -- 02/08/10 -- Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk...

Freshnews.com:  Feb 8 2010 3:13PM
Matching: breast mammary
Find similar documents
HTML
50%
Atossa Genetics, Inc. Launches Corporate Web Site Featuring New FDA-Approved Breast Cancer Risk Assessment Test
SEATTLE, WA -- (Marketwire) -- 02/08/10 -- Atossa Genetics : , Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic : risk assessment products for breast cancer : , announced today...
PR inside:  Feb 8 2010 2:03PM
Matching: breast mammary
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.